WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2022-11-15$0.47/sh+6,047$2,832→ 221,025 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.